From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

DCC – still boringly successful but now at a cuter price!

By Chris Bailey | Tuesday 10 November 2020

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

What an interesting last twenty-four hours in the financial markets. As always with big market shifts, sustainability comes with the reality of the headline new information flow. Aside from the obvious efficacy of any vaccine or treatment mitigation, the key to watch out for in my humble opinion is what happens with bond yields. I know hard-nosed equity investors forget about the bond market, but the reality is that it is a multi-asset relative world. So rising bond yields associated with stronger hopes about an economic recovery have a huge impact in terms of sector choice and market rotations. And from the perspective of having a bunch more ‘value’ than ‘growth’ stocks in my portfolio, I hope it continues. I am not sure how to pigeonhole DCC plc (DCC)…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



How is Wickes getting along?

Friday »


Tern – Is There More Bad News On The Way?

Thursday »


Zytronic – now a recovery Buy?



Buy Yourgene - target 0.6p



Keep avoiding Deliveroo shares

Friday »


Tharisa – Q1 report, still a value Buy